IACOBELLI, Stefano
IACOBELLI, Stefano
DIPARTIMENTO DI SCIENZE MEDICHE, ORALI E BIOTECNOLOGICHE; DIPARTIMENTO DI SCIENZE SPERIMENTALI E CLINICHE (attivo dal 23/11/2012 al 28/02/2015)
90K (Mac-2 BP) and galectins in tumor progression and metastasis.
2002-01-01 Grassadonia, Antonino; Tinari, Nicola; Iurisci, I; Piccolo, E; Cumashi, A; Innominato, P; D'Egidio, M; Natoli, Clara; Piantelli, Mauro; Iacobelli, Stefano
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells
1998-01-01 Fusco, Ornella; Querzoli, Patrizia; Nenci, Italo; Natoli, Clara; Brakebush, Cord; Ullrich, Axel; Iacobelli, Stefano
90K (Mac-2 BP) in human milk
1996-01-01 D'Ostilio, Nicola; Ullrich, Axel; Iacobelli, Stefano; Natoli, Clara; Sabatino, Giuseppe
90K (Mac-2 BP) in human milk.
1996-01-01 D'Ostilio, N; Sabatino, G; Natoli, Clara; Ullrich, A; Iacobelli, Stefano
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients.
1994-01-01 Rea, A; Palmieri, G; Tinari, Nicola; Natoli, Clara; Tagliaferri, P; Morabito, A; Grassadonia, Antonino; Bianco, A; Iacobelli, Stefano
90K protein in HIV infection: evidence of its release from peripheral blood mononuclear cells
1995-01-01 D'Egidio, Maurizia; DI STEFANO, P; Tentarelli, R; Alterio, L; Amatetti, Cristina; Iacobelli, Stefano; Natoli, Clara
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
1993-01-01 Natoli, Clara; Dianzani, F; Mazzotta, F; Balocchini, E; Pierotti, P; Antonelli, G; Iacobelli, Stefano
[Hairy cell leukemia: prognosis and treatment]
2006-01-01 Quaresima, M; Iacobelli, Stefano; Tempera, S; Frattarelli, N; Bizzoni, L; Anaclerico, B; Matturro, A; Cucchi, F; Tafuri, A; Pulsoni, A.
A 13-state homogeneous semi-Markov model for predicting the HIV disease evolution: a case study
2007-01-01 DI BIASE, Giuseppe; D'Amico, Guglielmo; DI GIROLAMO, A; Janssen, J; Iacobelli, Stefano; Tinari, Nicola; Manca, R.
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
1993-01-01 Briggs, Nc; Natoli, Clara; Tinari, Nicola; D'Egidio, M; Goedert, Jj; Iacobelli, Stefano
A comparative study of the antiinflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds
2007-01-01 Cumashi, A; Ushakova, Na; Preobrazhenskaya, Me; D'Incecco, Alessandra; Piccoli, A; Totani, L; Tinari, Nicola; Morozevich, Ge; Berman, Ae; Bilan, Mi; Usov, Ai; Ustuzhanina, Ne; Sanderson, Cj; Kelly, M; Rabinovich, Ga; Iacobelli, Stefano; Nifantiev, Ne
A multicenter phase II study of epirubicin (E) with low-dose herceptin (LD-H) as a first-line treatment in HER2 overexpressing metastatic breast cancer (MBC)
2007-01-01 De Tursi, M; Carella, C; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, S
A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer
2007-01-01 DE TURSI, Michele; Carella, Consiglia; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, Stefano
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis.
1997-01-01 Gridelli, C; Ianniello, G; Ambrosini, G; Mustacchi, G; Pedicini, T; Farris, A; Iacobelli, Stefano; Rossi, G; Moretti, G; Angelini, F; Delena, M; Dicarlo, A; Bonsignori, M; Sabbatini, R; Catalano, G; Rossi, A; Olivieri, A; Fina, P; Bianco, A.
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate
1996-01-01 Irtelli, Luciana; MARTINO MARIA, Teresa; Fiorentino, Bruno; Garufi, Carlo; Grassadonia, Antonino; Iacobelli, Stefano; Natoli, Clara
A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate
1996-01-01 Salini, Vincenzo; Irtelli, Luciana; MARTINO MARIA, Teresa; Fiorentino, Bruno; Garufi, Carlo; Grassadonia, Antonino; Iacobelli, Stefano; Natoli, Clara
A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate.
1996-01-01 Natoli, Clara; Salini, Vincenzo; Irtelli, L; Martino, Mt; Garufi, C; Grassadonia, Antonino; Fiorentino, B; Iacobelli, Stefano
A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer.
1995-01-01 Iacobelli, Stefano; Garufi, C; Irtelli, L; Martino, Mt; Santobuono, Fernanda; Vicario, G; Tinari, Nicola; Fiorentino, B; Innocenti, Paolo; Natoli, Clara
A phase II study of cisplatin, epirubicin, vindesine chemotherapy and lonidamine in advanced nonsmall cell lung cancer
1996-01-01 Irtelli, Luciana; MARTINO MARIA, Teresa; Iacobelli, Stefano; Natoli, Clara
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer.
2007-01-01 Natoli, Clara; Cianchetti, Ettore; Tinari, Nicola; Angelucci, D; Grassadonia, Antonino; Zilli, Marinella; Ficorella, C; Ricevuto, E; Grossi, Simona; DE TURSI, Michele; Carella, Consiglia; Rispoli, Ai; Iacobelli, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 90K (Mac-2 BP) and galectins in tumor progression and metastasis. | 2002 | Grassadonia, Antonino; Tinari, Nicola; Iurisci, I; Piccolo, E; Cumashi, A; Innominato, P; D'Egidio, M; Natoli, Clara; Piantelli, Mauro; Iacobelli, Stefano | |
| 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells | 1998 | Fusco, Ornella; Querzoli, Patrizia; Nenci, Italo; Natoli, Clara; Brakebush, Cord; Ullrich, Axel; Iacobelli, Stefano | |
| 90K (Mac-2 BP) in human milk | 1996 | D'Ostilio, Nicola; Ullrich, Axel; Iacobelli, Stefano; Natoli, Clara; Sabatino, Giuseppe | |
| 90K (Mac-2 BP) in human milk. | 1996 | D'Ostilio, N; Sabatino, G; Natoli, Clara; Ullrich, A; Iacobelli, Stefano | |
| 90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. | 1994 | Rea, A; Palmieri, G; Tinari, Nicola; Natoli, Clara; Tagliaferri, P; Morabito, A; Grassadonia, Antonino; Bianco, A; Iacobelli, Stefano | |
| 90K protein in HIV infection: evidence of its release from peripheral blood mononuclear cells | 1995 | D'Egidio, Maurizia; DI STEFANO, P; Tentarelli, R; Alterio, L; Amatetti, Cristina; Iacobelli, Stefano; Natoli, Clara | |
| 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. | 1993 | Natoli, Clara; Dianzani, F; Mazzotta, F; Balocchini, E; Pierotti, P; Antonelli, G; Iacobelli, Stefano | |
| [Hairy cell leukemia: prognosis and treatment] | 2006 | Quaresima, M; Iacobelli, Stefano; Tempera, S; Frattarelli, N; Bizzoni, L; Anaclerico, B; Matturro, A; Cucchi, F; Tafuri, A; Pulsoni, A. | |
| A 13-state homogeneous semi-Markov model for predicting the HIV disease evolution: a case study | 2007 | DI BIASE, Giuseppe; D'Amico, Guglielmo; DI GIROLAMO, A; Janssen, J; Iacobelli, Stefano; Tinari, Nicola; Manca, R. | |
| A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. | 1993 | Briggs, Nc; Natoli, Clara; Tinari, Nicola; D'Egidio, M; Goedert, Jj; Iacobelli, Stefano | |
| A comparative study of the antiinflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds | 2007 | Cumashi, A; Ushakova, Na; Preobrazhenskaya, Me; D'Incecco, Alessandra; Piccoli, A; Totani, L; Tinari, Nicola; Morozevich, Ge; Berman, Ae; Bilan, Mi; Usov, Ai; Ustuzhanina, Ne; Sanderson, Cj; Kelly, M; Rabinovich, Ga; Iacobelli, Stefano; Nifantiev, Ne | |
| A multicenter phase II study of epirubicin (E) with low-dose herceptin (LD-H) as a first-line treatment in HER2 overexpressing metastatic breast cancer (MBC) | 2007 | De Tursi, M; Carella, C; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, S | |
| A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer | 2007 | DE TURSI, Michele; Carella, Consiglia; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, Stefano | |
| A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis. | 1997 | Gridelli, C; Ianniello, G; Ambrosini, G; Mustacchi, G; Pedicini, T; Farris, A; Iacobelli, Stefano; Rossi, G; Moretti, G; Angelini, F; Delena, M; Dicarlo, A; Bonsignori, M; Sabbatini, R; Catalano, G; Rossi, A; Olivieri, A; Fina, P; Bianco, A. | |
| A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate | 1996 | Irtelli, Luciana; MARTINO MARIA, Teresa; Fiorentino, Bruno; Garufi, Carlo; Grassadonia, Antonino; Iacobelli, Stefano; Natoli, Clara | |
| A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate | 1996 | Salini, Vincenzo; Irtelli, Luciana; MARTINO MARIA, Teresa; Fiorentino, Bruno; Garufi, Carlo; Grassadonia, Antonino; Iacobelli, Stefano; Natoli, Clara | |
| A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate. | 1996 | Natoli, Clara; Salini, Vincenzo; Irtelli, L; Martino, Mt; Garufi, C; Grassadonia, Antonino; Fiorentino, B; Iacobelli, Stefano | |
| A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer. | 1995 | Iacobelli, Stefano; Garufi, C; Irtelli, L; Martino, Mt; Santobuono, Fernanda; Vicario, G; Tinari, Nicola; Fiorentino, B; Innocenti, Paolo; Natoli, Clara | |
| A phase II study of cisplatin, epirubicin, vindesine chemotherapy and lonidamine in advanced nonsmall cell lung cancer | 1996 | Irtelli, Luciana; MARTINO MARIA, Teresa; Iacobelli, Stefano; Natoli, Clara | |
| A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. | 2007 | Natoli, Clara; Cianchetti, Ettore; Tinari, Nicola; Angelucci, D; Grassadonia, Antonino; Zilli, Marinella; Ficorella, C; Ricevuto, E; Grossi, Simona; DE TURSI, Michele; Carella, Consiglia; Rispoli, Ai; Iacobelli, Stefano |